1 / 16

Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Analysis | Coherent Market Insights

Read here the market research report on u201cSurgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Marketu201d published by CMI team.

Download Presentation

Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Analysis | Coherent Market Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Coherent Market InsightS Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

  2. Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market Analysis (2020-2027) • Surgical hemostat is a surgical tool used in many surgical procedures to control bleeding. Surgical hemostats covered in this report include thrombin-based, combination hemostats, oxidized regenerated cellulose-based, gelatin-based, and collagen-based. Internal tissue sealants are typically used in surgeries to bind or hold internal tissues such as blood vessels, internal organs, bone cartilage, dura matter and others. • The global surgical hemostats, internal tissue sealants and adhesion barriers market is estimated to account for US$ 4,231.4 Mn in terms of value in 2020 and is expected to reach US$ 7,346.7 Mn by the end of 2027

  3. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Drivers • Increasing number of surgical procedures is expected to propel growth of the global surgical hemostats, internal tissue sealants and adhesion barriers market over the forecast period. For instance, according to ‘Surgical operations and procedures statistics’ of Eurostat in November 2019, at least 1.4 million caesarean sections performed in the EU in 2017. • Moreover, high incidence of early postoperative small bowel obstruction is also expected to aid in growth of the market.

  4. S • High number of cardiovascular procedures is expected to propel growth of the global surgical hemostats, internal tissue sealants and adhesion barriers market over the forecast period. For instance, according to American Heart Association 2019 Heart Disease and Stroke Statistics, 1,016,000 cardiac catheterizations and 3,244 heart transplants were performed in the U.S. in 2014 and 2017, respectively.       • Statistics: • Hemostat held dominant position in the global surgical hemostats, internal tissue sealants and adhesion barriers market in 2019, accounting for 41.1% share in terms of value, followed by Internal Tissue Sealants, and adhesion barriers respectively

  5. s

  6. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Restraints • Bringing a single new product of hemostat, tissue sealant or adhesion barriers in the market costs tremendous investment and long duration. For instance, time involved in the clinical and pre-clinical trials for these products is as high as 10 years or more. • Stringent federal approval procedures for new products are exerting significant difficulties for market development. Furthermore, some surgical sealants demonstrate less glue quality and have restricted applications. Such scenario also limits growth of the market.

  7. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Opportunities • Increasing incidence of injuries and burns is expected to offer lucrative growth opportunities for players in the market. For instance, according to the World Health Organization’s March 2018 key facts,  an estimated 180 000 deaths every year are caused by burns – the vast majority occur in low- and middle-income countries. • Use of bone glue, tissue sealants & bio sealants helps reduce cross-contamination, aids in healing process, and decreases blood loss due to surgical stiches and staplers and improves quality of patient care. Increasing awareness among physicians about benefits such as reduced cost of post-surgical complications treatment and reduced hospital stay post-surgery due to faster healing and recovery of surgical wounds is also expected to aid in growth of the market.

  8. s

  9. Market Trends/Key Takeaways • Increasing prevalence of cardiovascular disease (CVD) is expected to boost growth of the market in North America. For instance, according to American Heart Association 2019 Heart Disease and Stroke Statistics, CVD was responsible for 840,768 deaths (635,260 cardiac) in 2016 in the U.S. • Increasing number of surgical procedures is expected to aid in growth of the market in Asia Pacific. For instance, according to Australian Institute of Health and Welfare’s Hospitals at a glance 2017–18 report updated in August 2019, admissions for emergency surgery increased between 2016-2017 and 2017-2018 by 2.9% in public hospitals and by 5.1% in private hospitals in Australia.

  10. s

  11. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Competitive Landscape  • Major players operating in the global surgical hemostats, internal tissue sealants and adhesion barriers market include, Ethicon (Johnson & Johnson), Baxter International Inc., Integra LifeSciences Holdings Corporation, Pfizer Inc., Tissuemed Ltd., Sanofi, Braun Melsungen AG, C.R. Bard, Inc., CryoLife, Inc., Cohera Medical, Inc., and CSL Behring.

  12. Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Key Developments  • Major players in the market are focused on launching new products to expand their product portfolio. For instance, in March 2020, Ethicon, part of the Johnson & Johnson Medical Devices Companies, launched SURGICEL POWDER ABSORBABLE HEMOSTAT in Australia, New Zealand, and Thailand. • Major players in the market are also focussed on adopting M&A strategies to expand their product portfolio. For instance, in February 2020, Baxter International Inc. competed acquisition of Seprafilm Adhesion Barrier and related assets from Sanofi.

  13. Request sample copy here • Request PDF brochure here • Request Customization here • Talk to Analyst • Buy Now • Reference: • https://www.coherentmarketinsights.com/market-insight/surgical-hemostats-internal-tissue-sealants-and-adhesion-barriers-market-3721

  14. About Us: • Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. • What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

  15. Contact Us: • Mr. Shah • Coherent Market Insights Pvt. Ltd. • Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S. • Phone: +1-206-701-6702 • Email :sales@coherentmarketinsights.com

  16. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/

More Related